Freeport-McMoRan heads into its June 10 earnings report having absorbed one of the sharpest single-session losses in its recent history — a 9.1% fall on June 5 — while the entire copper complex crumbled around it.
The selloff was not an FCX-specific story. Every major copper peer fell hard on the same day: SCCO dropped 10.9%, HBM fell 14.8%, NGEX lost 15.4%, and LUN shed 12.6%. The synchronized move points to a macro or commodity catalyst driving the group, not company-specific news. FCX actually held up better than most of its closest peers on the day, though the 3.6% decline over the past week leaves the stock at $63.37 — roughly 12% off its recent high of $71.72. The one-month return remains positive at 9.9%, a reminder that this week's pain followed a strong rally.
Despite the sharp price move, the positioning data shows remarkably little short conviction behind it. Short interest has barely shifted, running at just 2% of the free float — low by any measure. Borrow costs confirm the picture: at 0.46% annualized, this is effectively free to borrow. Availability is extraordinarily loose, with over 8,000% availability relative to current short interest, meaning the lending market has not been touched by the selloff. The ORTEX short score of 30.6 sits near the lower end of its range, suggesting no meaningful build in bearish positioning. If anything, short sellers were net sellers of shorts last week, trimming positions by 0.4% over seven days. This is a macro-driven correction, not a short attack.
Options positioning is near-neutral. The put/call ratio has edged up to 0.96, marginally above its 20-day average of 0.95 — a z-score of just 0.5. The 52-week high on the PCR is 1.08, well above current levels, meaning the options market has not rushed to buy protection. What the options data does confirm is that the reaction to last quarter's print was severe: FCX fell 13.2% on the day of its April 23 report and extended losses to 17.9% over the following five days. That prior reaction adds meaningful context to how the June 10 print is being framed.
Analysts are broadly constructive, with the Street consensus mean price target around $68.27 — roughly 8% above where the stock closed June 5. Barclays initiated coverage at Overweight with a $77 target in late May, and UBS lifted its target to $75 while reiterating Buy around the same time. The bull case centers on the Grasberg licence extension, copper-gold price leverage, and an improving free cash flow profile. Bears point to weaker-than-expected production guidance, EBITDA estimate cuts, and a valuation that looks stretched versus peers — Morgan Stanley downgraded to Equal-Weight in late April and trimmed its target to $66. The EV/EBITDA multiple has been compressing, down from its 30-day high, while the P/E ratio has eased over the past week — both consistent with the stock coming off a peak.
The June 10 print is therefore less about FCX's long-term copper thesis and more about whether production numbers and cost guidance can justify a re-entry after a violent two-day dislocation that erased a full month's gains in hours.
See the live data behind this article on ORTEX.
Open FCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
